Table 4.
Results comparison to other T2DM COI studies
| Cost-of-illness study of T2DM Colombia | Cost-of-illness study of T2DMIran | Rosibel de los Angeles T2DM Mexico | CODE-2 B. Jonsson T2DM Europe | Luciana R. Bahia T2DM Brazil | Natalie B. Borges T2DM Brazil | |
|---|---|---|---|---|---|---|
| Year of publication | 2009 | 2011 | 2010 | 2002 | 2011 | |
| Total cost* | 2.7 billion | 3.78 billion | 4.5 billion | EUR 29 billion | –– | –– |
| Total annual cost | 847 | 1707 | 3194** | EUR | 2108 | 1844 |
| per patient* | 2834** | |||||
| Indirect cost | 66% | 51% | –– | –– | 33% | 45% |
| Direct cost | 34% | 49% | –– | –– | 63% | 55% |
| Medication | 47% | 46%*** | –– | 7% | 48% | 42% |
| Laboratory | –– | –– | –– | 21% | –– | 34%**** |
| Procedures and | –– | –– | 18% | 55% | –– | 14% |
| Hospitalizations Consultations | –– | –– | –– | 18% | –– | 4% |
*The costs in all studies are shown in US$, except where indicated.
**Indirect costs were not calculated in these studies.
***This percentage refers only to patients without complications.
****This percentage refers to the cost of laboratory exams (7%) added to those of strips (27%).